This patent teaches that Insulin Like Growth Factor-1 is useful for the treatment of polycystic kidney disease. Given the stimulatory effects of this hormone on stem cells, it is interesting to see if this patent can be used with exogenous stem cell therapy.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.